Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) EVP Brian Farley sold 5,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Thursday, December 14th. The shares were sold at an average price of $14.35, for a total value of $71,750.00. Following the transaction, the executive vice president now owns 191,607 shares of the company’s stock, valued at approximately $2,749,560.45. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Shares of Allscripts Healthcare Solutions Inc (NASDAQ MDRX) traded down $0.04 during midday trading on Thursday, reaching $14.68. The company’s stock had a trading volume of 1,266,900 shares, compared to its average volume of 2,385,573. The stock has a market capitalization of $2,659.62, a price-to-earnings ratio of 34.23, a price-to-earnings-growth ratio of 2.62 and a beta of 1.34. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.20. Allscripts Healthcare Solutions Inc has a 52 week low of $10.19 and a 52 week high of $15.20.

Institutional investors have recently bought and sold shares of the company. Bank of Montreal Can increased its position in shares of Allscripts Healthcare Solutions by 6.9% during the second quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock worth $135,000 after acquiring an additional 689 shares during the period. World Asset Management Inc grew its stake in shares of Allscripts Healthcare Solutions by 0.7% during the second quarter. World Asset Management Inc now owns 11,419 shares of the software maker’s stock worth $146,000 after purchasing an additional 81 shares in the last quarter. ETF Managers Group LLC acquired a new position in shares of Allscripts Healthcare Solutions during the second quarter worth $152,000. Shelton Capital Management acquired a new position in shares of Allscripts Healthcare Solutions during the second quarter worth $170,000. Finally, Sheaff Brock Investment Advisors LLC acquired a new position in shares of Allscripts Healthcare Solutions during the third quarter worth $174,000.

MDRX has been the subject of a number of recent research reports. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Tuesday, October 10th. Cowen upgraded Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $13.00 to $16.00 in a research note on Monday, September 11th. Royal Bank of Canada began coverage on Allscripts Healthcare Solutions in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $17.00 price target for the company. Jefferies Group set a $17.00 price target on Allscripts Healthcare Solutions and gave the company a “buy” rating in a research note on Friday, August 25th. Finally, Maxim Group restated a “buy” rating and issued a $16.00 price target on shares of Allscripts Healthcare Solutions in a research note on Friday, November 3rd. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and twelve have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $15.06.

COPYRIGHT VIOLATION WARNING: This story was published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at https://www.watchlistnews.com/insider-selling-allscripts-healthcare-solutions-inc-mdrx-evp-sells-71750-00-in-stock/1776402.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Insider Buying and Selling by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.